DPP4 and type 2 diabetes mellitus: Compared to previous studies on antidiabetic treatments in both PTDM patients and the broader type 2 diabetes population, our findings largely align with established evidence regarding the efficacy of insulin, SGLT2i, and DPP-4 inhibitors.